StockData
Minerva Neurosciences, Inc. logo

Minerva Neurosciences, Inc. (NERV) stock

NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$2.16−0.04 (-1.82%)

Close on Nov 17, 2026Market cap $103.14MP/E –Yield –

Minerva Neurosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Minerva Neurosciences's price to sales ratio was 1.9× on Jul 30, 2021.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Jul 30, 20211.9×−0.5
2020Dec 31, 20202.4×–

More Minerva Neurosciences figures

See a number that looks wrong?